Email:
Tel:

TRHR-Targeted Drug Discovery Services

Whatever information you want about TRHR-targeted drug discovery, you can find it here. For more details or related services, please feel free to contact us.

Introduction

Introduction

Thyrotropin-releasing hormone receptor is also known as TRHR. This gene encodes a G protein-coupled receptor for thyrotropin-releasing hormone (TRH). Upon binding to TRH, this receptor activates the inositol phospholipid-calcium-protein kinase C transduction pathway. Mutations in this gene have been associated with generalized thyrotropin-releasing hormone resistance. [provided by RefSeq, Sep 2011]

TRHR-Targeted Drug Discovery Services

Direction of Drugs Discovery

Direction of Drugs Discovery

• TRHR Modulator
• TRHR Inhibitor
• TRHR Agonist
• Developing New Clinical Effects on TRHR from Existing Drugs

Drugs

Drugs

• TRHR Modulator- Posatirelin, protirelin, AZETIRELIN, JTP-2942
• TRHR Inhibitor- CORYMBONE B, C4X-101
• TRHR Agonist- MeTRH

What We Offer

Target Testing Target Testing

CD BioSciences provides TRHR testing services by WB, IF, ICC, or IHC assay. The results of TRHR testing are used to evaluate the activities of candidates against TRHR or targeted diseases. You can choose one or more testing ways to detect the level of TRHR according to your experiment.

Hit Identification Hit Identification (show more)

The goal of early drug discovery is to find novel lead compounds that have the desired potency, selectivity, and ADMET properties for pre-clinical evaluation.
CD BioSciences offers hit identification services to make your finding of targeted compounds more successful and faster.
• High-Throughput Screening
• TRHR-Targeted in Silico Virtual Screening
• Fragment-Based Screening
• High-Content Screening

Antibody Drugs Development Services Antibody Drugs Development Services (show more)

Antibody drugs exhibit many incomparable advantages, such as high specificity, affinity, and efficiency, which is an emerging direction on targeted drug development. CD BioSciences provides comprehensive services on TRHR-targeted antibody drugs development with professional technology, extensive experience, and advanced equipment.
• Antibody Preparation Services
• Phage Display Services
• Antibody-Drug Conjugates
• Bispecific Antibody Services
• Antibody Humanization Services

Pharmacological Experiment Pharmacological Experiments (show more)

We will create a specific experimental plan according to your requirements, including but not limited to
• Pharmacokinetics / Pharmacodynamics
• Pharmacodynamics
• Pharmacokinetics
• Safety Pharmacology

Disease Models Screening Disease Models Screening (show more)

We will create specific disease models to accelerate your targeted drug discovery project, including but not limited to
• Diseases—Central nervous system disease, pain, etc.
CD BioSciences will establish the specific disease models according to your requirements to evaluate the inhibitory activity of your candidates targeted TRHR. We have various cell lines and the species of our animal models cover rats, mice, rabbits, dogs, and non-human primates.

Inquire Us Inquire Us

References

  1. 1. Stelzer G.; et al. The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analysis , Current Protocols in Bioinformatics(2016), 54:1.30.1 - 1.30.33.doi: 10.1002 / cpbi.5.
    2. Wishart DS; et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008 Jan;36(Database issue): D901-6.
    3. Y. Zhou; et al. Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents. Nucleic Acids Research. 50(D1): 1398-1407 (2022). PMID: 34718914.
  • Tel:
  • Email:
Copyright © CD BioSciences. All Rights Reserved.
Top